Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032906HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS10040510HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS10042489HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001392HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001393HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001394HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30013875HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30088317HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019456HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019457HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TCGA Plot Options
Drug Information
GeneJAK1
DrugBank IDDB15091
Drug NameUpadacitinib
Target IDBE0004145
UniProt IDP23458
Regulation Typeinhibitor
PubMed IDs31692920; 30886973
CitationsBiggioggero M, Becciolini A, Crotti C, Agape E, Favalli EG: Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis. Drugs Context. 2019 Oct 24;8:212595. doi: 10.7573/dic.212595. eCollection 2019.@@Parmentier JM, Voss J, Graff C, Schwartz A, Argiriadi M, Friedman M, Camp HS, Padley RJ, George JS, Hyland D, Rosebraugh M, Wishart N, Olson L, Long AJ: In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). BMC Rheumatol. 2018 Aug 28;2:23. doi: 10.1186/s41927-018-0031-x. eCollection 2018.
GroupsApproved; Investigational
Direct Classification
SMILESCC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F
Pathways
PharmGKB
ChEMBLCHEMBL3622821